Literature DB >> 9358021

Bystander effects in enzyme/prodrug gene therapy.

F Paillard.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9358021     DOI： 10.1089/hum.1997.8.15-1733

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  4 in total

Review 1.  Gene Delivery in Neuro-Oncology.

Authors:  Karan Dixit; Priya Kumthekar
Journal:  Curr Oncol Rep       Date:  2017-09-02       Impact factor: 5.075

2.  Cancer gene therapy using a replication-competent herpes simplex virus type 1 vector.

Authors:  S S Yoon; N M Carroll; E A Chiocca; K K Tanabe
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

3.  A Fusion Protein of RGD4C and β-Lactamase Has a Favorable Targeting Effect in Its Use in Antibody Directed Enzyme Prodrug Therapy.

Authors:  Hao Wang; Xiao-Liang Zhou; Wei Long; Jin-Jian Liu; Fei-Yue Fan
Journal:  Int J Mol Sci       Date:  2015-04-28       Impact factor: 5.923

Review 4.  Gene therapy for malignant glioma.

Authors:  Hidehiro Okura; Christian A Smith; James T Rutka
Journal:  Mol Cell Ther       Date:  2014-07-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.